• David Charles at Future Unpacked, by Food & Drink Business + PKN LIVE 2017
    David Charles at Future Unpacked, by Food & Drink Business + PKN LIVE 2017
  • Peter Taitoko at Future Unpacked, by Food & Drink Business + PKN LIVE 2017
    Peter Taitoko at Future Unpacked, by Food & Drink Business + PKN LIVE 2017
Close×

On the eve of the official opening of Birch & Waite's new food manufacturing facility in Revesby, Sydney, we learned how the factory has been designed for the future.

GM of Birch & Waite, David Charles and MD of RMR Process, Peter Taitoko presented on the design thinking behind the mid-tier food manufacturer's new facility, where some of the company's more innovative products will be processed and packed.

David Charles gave a background to the company and its drive for innovation and quality, and described some of the new technology in place at the plant, including the latest thermoprocessing equipment and specialised sachet filling and packing line.

Peter Taitoko explained the process that his team followed with Birch & Waite to save them millions of dollars in plant design and construction costs, by establishing what the company needs now and building that, but designing and putting in place the necessary infrastructure to accommodate future automation and expansion.

Our editorial team will be attending the opening this Friday, and will bring you the full story in next week's enews.

Food & Drink Business

Australia’s first social enterprise bakery, The Bread & Butter Project, has graduated its latest group of bakers, with its largest ever cohort marking the program’s 100th graduate.

The University of Sydney and Peking University have launched a Joint Centre for Food Security and Sustainable Agricultural Development, which will support research into improving the sustainability and security of food systems in Australia and China.

Sydney-based biotech company, All G, has secured regulatory approval in China to sell recombinant (made from microbes, not cows) lactoferrin. CEO Jan Pacas says All G is the first company in the world to receive the approval, and recombinant human lactoferrin is “next in line”.